Extracellular vesicle-associated microRNA-221-3p secreted by drug-resistant lung cancer cells targets HMBOX1 to promote the progression of lung cancer.

Cancer Gene Therapy
Jun LiJing Wang

Abstract

Extracellular vesicles (EVs) have received increasing attention for their role as possible regulators of cancer. miR-221-3p is a microRNA (miR) up-regulated in EVs secreted by drug-resistant A549-GR lung cancer cells. However, the underlying mechanism through which miR-221-3p-containing EVs regulate the progression of lung cancer remains elusive. Here, we attempted to reveal the mechanism by which miR-221-3p-containing EVs secreted by drug-resistant lung cancer cells regulate the functions of surrounding cells during the progression of lung cancer. A gemcitabine-sensitive lung cancer cell line was treated with isolated drug-resistant lung cancer EVs followed by an evaluation of the proliferation and migration of sensitive lung cancer cell lines and their resistance to gemcitabine treatment. Moreover, the miR-221-3p target gene HMBOX1 was identified by the Targetscan database while the progression of lung cancer was detected by knocking down miR-221-3p or overexpressing HMBOX1, or by treating sensitive cell lines with Akt/mTOR activator and inhibitor, respectively. Furthermore, an in vivo study was performed to validate the relationship between miR-221-3p and HMBOX1 and their roles in the progression of lung cancer. The prolifer...Continue Reading

References

Mar 25, 2006·Future Oncology·L ToschiF Cappuzzo
May 29, 2009·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·J-L QuY-P Liu
Apr 12, 2011·Cancer Research·Joshua L HoodSamuel A Wickline
Feb 20, 2013·The Journal of Cell Biology·Graça Raposo, Willem Stoorvogel
Aug 2, 2014·European Journal of Pharmacology·Lucas de Sousa Cavalcante, Gisele Monteiro
Feb 3, 2015·Cancer Medicine·Ryo YamashitaYoshinori Hasegawa
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
Aug 1, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Guangyuan SunBing Li
Aug 10, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Yoshimasa TokunagaHiroyasu Yokomise
Dec 17, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zhen-Hua WuXi-Chun Hu
Jan 29, 2016·Journal of Experimental & Clinical Cancer Research : CR·Yang LiuQiong Wu
Jan 23, 2018·The American Journal of Pathology·Tanyalak ParimonPeter Chen
May 2, 2018·Biochemical and Biophysical Research Communications·Yun-Liang YuNan Lu
Apr 22, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Nannan DiaoNan Lu
Mar 29, 2020·International Journal of Medical Sciences·Haiyang HuQiang Lin

❮ Previous
Next ❯

Methods Mentioned

BETA
transfecting
transfection
protein assay
PCR
confocal microscopy

Software Mentioned

GEPIA
miRWalk
TargetScan
miRDB
SPSS
DIANA TOOLS

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.